To study the incidence of anemia in HIV-infected children on zidovudine-based highly active antiretroviral therapy regimen.
作者信息
Maurya Manisha, Badrinath Shruthi, Singh Dharmendra K, Rai Ruchi
机构信息
Department of Pediatrics, MLN Medical College, Allahabad, Uttar Pradesh, India.
出版信息
Indian J Sex Transm Dis AIDS. 2020 Jan-Jun;41(1):135-136. doi: 10.4103/ijstd.IJSTD_79_17. Epub 2020 Jun 18.
Abstract
摘要
相似文献
1
To study the incidence of anemia in HIV-infected children on zidovudine-based highly active antiretroviral therapy regimen.研究接受基于齐多夫定的高效抗逆转录病毒治疗方案的HIV感染儿童中贫血的发生率。
Indian J Sex Transm Dis AIDS. 2020 Jan-Jun;41(1):135-136. doi: 10.4103/ijstd.IJSTD_79_17. Epub 2020 Jun 18.
2
Evaluation of incidence of zidovudine induced anemia in Indian human immunodeficiency virus positive patients in comparison with stavudine based highly active antiretroviral therapy.与基于司他夫定的高效抗逆转录病毒疗法相比，评估齐多夫定诱导的贫血在印度人类免疫缺陷病毒阳性患者中的发生率。
Int J Risk Saf Med. 2011;23(3):171-80. doi: 10.3233/JRS-2011-0531.
3
A prospective study of haematological changes after switching from stavudine to zidovudine-based antiretroviral treatment in HIV-infected children.一项关于感染HIV儿童从司他夫定转换为基于齐多夫定的抗逆转录病毒治疗后血液学变化的前瞻性研究。
Int J STD AIDS. 2016 Nov;27(13):1145-1152. doi: 10.1177/0956462414522986. Epub 2014 Feb 10.
4
Magnitude and correlates of moderate to severe anemia among adult HIV patients receiving first line HAART in Northwestern Tanzania: a cross sectional clinic based study.坦桑尼亚西北部接受一线高效抗逆转录病毒治疗的成年艾滋病患者中重度贫血的严重程度及其相关因素：一项基于诊所的横断面研究。
Pan Afr Med J. 2016 Feb 4;23:26. doi: 10.11604/pamj.2016.23.26.8268. eCollection 2016.
5
Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.阿巴卡韦-拉米夫定-齐多夫定与茚地那韦-拉米夫定-齐多夫定用于初治HIV感染成人的抗逆转录病毒治疗：一项随机等效性试验。
JAMA. 2001 Mar 7;285(9):1155-63. doi: 10.1001/jama.285.9.1155.
6
High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.在印度东部，HIV 感染患者中齐多夫定诱导贫血的发生率较高。
Indian J Med Res. 2010 Oct;132:386-9.
7
8
HIV-infected children in the Asia-Pacific region with baseline severe anemia: antiretroviral therapy and outcomes.亚太地区基线患有严重贫血的艾滋病毒感染儿童：抗逆转录病毒疗法及治疗结果
Asian Biomed (Res Rev News). 2016 Jun;10(3):229-234.
9
An antiretroviral regimen containing 6 months of stavudine followed by long-term zidovudine for first-line HIV therapy is optimal in resource-limited settings: a prospective, multicenter study in China.含 6 个月司他夫定随后长期齐多夫定的抗逆转录病毒治疗方案是资源有限地区一线 HIV 治疗的最佳选择：中国一项前瞻性、多中心研究。
Chin Med J (Engl). 2014;127(1):59-65.
10
Changes in hematologic parameters and efficacy of thymidine analogue-based, highly active antiretroviral therapy: a meta-analysis of six prospective, randomized, comparative studies.基于胸苷类似物的高效抗逆转录病毒疗法的血液学参数变化及疗效：六项前瞻性、随机、对照研究的荟萃分析
Clin Ther. 2004 Jan;26(1):92-7. doi: 10.1016/s0149-2918(04)90009-4.
本文引用的文献
1
Incidence and predictors of severe anemia in Asian HIV-infected children using first-line antiretroviral therapy.亚洲接受一线抗逆转录病毒治疗的 HIV 感染儿童重度贫血的发生率和预测因素。
Int J Infect Dis. 2013 Oct;17(10):e806-10. doi: 10.1016/j.ijid.2013.04.006. Epub 2013 Jun 10.
2
High incidence of zidovudine induced anaemia in HIV infected patients in eastern India.在印度东部，HIV 感染患者中齐多夫定诱导贫血的发生率较高。
Indian J Med Res. 2010 Oct;132:386-9.
3
Incidence of anaemia among HIV-infected patients treated with highly active antiretroviral therapy.接受高效抗逆转录病毒治疗的艾滋病毒感染患者中的贫血发生率。
HIV Med. 2007 Nov;8(8):483-90. doi: 10.1111/j.1468-1293.2007.00500.x.
4
Prevalence, incidence and predictors of severe anaemia with zidovudine-containing regimens in African adults with HIV infection within the DART trial.在DART试验中，非洲成人HIV感染者使用含齐多夫定方案时严重贫血的患病率、发病率及预测因素。
Antivir Ther. 2006;11(6):741-9. doi: 10.1177/135965350601100612.
5
A multicenter trial of oral zidovudine in children with advanced human immunodeficiency virus disease. The Protocol 043 Study Group.一项关于口服齐多夫定治疗晚期人类免疫缺陷病毒病儿童的多中心试验。043方案研究组。
N Engl J Med. 1991 Apr 11;324(15):1018-25. doi: 10.1056/NEJM199104113241503.
Zotero 插件